889
Views
5
CrossRef citations to date
0
Altmetric
Trials

An online non-meditative mindfulness intervention for people with ALS and their caregivers: a randomized controlled trial

, , , , &
Pages 116-127 | Received 03 Dec 2020, Accepted 25 Apr 2021, Published online: 22 May 2021

References

  • van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084–98.
  • Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Lomen-Hoerth C, et al. Longitudinal screening detects cognitive stability and behavioral deterioration in ALS patients. Behav Neurol. 2018;2018:1–7.
  • Lulé D, Ludolph AC, Kübler A. Psychological morbidity in amyotrophic lateral sclerosis: depression, anxiety, hopelessness. In: Pagnini F, Simmons Z, eds. Amyotrophic lateral sclerosis: understanding and optimizing quality of life and psychological well-being. Oxford: Oxford University Press; 2018:33–48.
  • Zaccheo V, Simmons Z. Quality of life in ALS: what is it and how do we measure it? In: Pagnini F, Simmons Z, eds. Amyotrophic lateral sclerosis: understanding and optimizing quality of life and psychological well-being. Oxford, UK: Oxford University Press; 2018:17.
  • Pagnini F, Simmons Z, Corbo M, Molinari E. Amyotrophic lateral sclerosis: time for research on psychological intervention? Amyotroph Lateral Scler. 2012;13:416–7.
  • Kleinbub JR, Palmieri A, Broggio A, Pagnini F, Enrico B, Sambin M, et al. Hypnosis-based psychodynamic treatment in ALS: a longitudinal study on patients and their caregivers. Front Psychol 2015;6:822.
  • Díaz JL, Sancho J, Barreto P, Bañuls P, Renovell M, Servera E. Effect of a short-term psychological intervention on the anxiety and depression of amyotrophic lateral sclerosis patients. J Health Psychol. 2016;21:1426–35.
  • van Groenestijn AC, Schröder CD, Visser-Meily JMA, Reenen E-V, Veldink JH, van den Berg LH. Cognitive behavioural therapy and quality of life in psychologically distressed patients with amyotrophic lateral sclerosis and their caregivers: results of a prematurely stopped randomized controlled trial. Amyotroph Lat Scl Frontotemp Degen. 2015;16:309–15.
  • Bentley B, O’Connor M, Kane R, Breen LJ. Feasibility, acceptability, and potential effectiveness of dignity therapy for people with motor neurone disease. PLoS One. 2014;9:e96888.
  • Pagnini F, Di Credico C, Gatto R, Fabiani V, Rossi G, Lunetta C, et al. Meditation training for people with amyotrophic lateral sclerosis and their caregivers. J Altern Complement Med. 2014;20:272–5.
  • Pagnini F, Marconi A, Tagliaferri A, Manzoni GM, Gatto R, Fabiani V, et al. Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial. Eur J Neurol. 2017;24:578–86.
  • Marconi A, Gragnano G, Lunetta C, Gatto R, Fabiani V, Tagliaferri A, et al. The experience of meditation for people with amyotrophic lateral sclerosis and their caregivers – a qualitative analysis. Psychol Health Med. 2016;21:762–8.
  • Pagnini F, Phillips D, Bosma CM, Bosma MC, Reece A, Langer E. Mindfulness, physical impairment and psychological well-being in people with amyotrophic lateral sclerosis. Psychol Health. 2015;30:503–17.
  • Pagnini F, Bosma C, Phillips D, Reece A, Langer E. Mindfulness as a protective factor for the burden of caregivers of Amyotrophic Lateral Sclerosis patients. J Clin Psychol 2016;72:101–11.
  • Pagnini F, Philips D. Being mindful about mindfulness. Lancet Psychiat. 2015;2:288–9.
  • Langer EJ. Mindfulness. Reading, MA: Addison-Wesley/Addison Wesley Longman; 1989.
  • Langer E, Moldoveanu M. The construct of mindfulness. J Social Isssues. 2000;56:1–9.
  • Carson SL, Langer EJ. Mindful practice for clinicians and patients. In: Haas L, ed. Handbook of primary care psychology. New York, NY: Oxford University Press; 2004:173–86.
  • Pagnini F, Phillips D, Volpato E, Banfi P, Langer E. Mindfulness and mindlessness and ALS. In: Pagnini F, Simmons Z, eds. Amyotrophic lateral sclerosis: understanding and optimizing quality of life and psychological well-being. Oxford, UK: Oxford University Press; 2018.
  • Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
  • Langer E. The power of mindful learning. Reading, MA: Addison-Wesley/Addison Wesley Longman; 1997.
  • Simmons Z, Felgoise SH, Bremer BA, Walsh SM, Hufford DJ, Bromberg MB, et al. The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology 2006;67:1659–64.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
  • Montes J, Levy G, Albert S, Kaufmann P, Buchsbaum R, Gordon PH, et al. Development and evaluation of a self-administered version of the ALSFRS-R. Neurology 2006;67:1294–6.
  • Maier A, Holm T, Wicks P, Steinfurth L, Linke P, Munch C, et al. Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial. Amyotroph Lateral Scler. 2012;13:210–6.
  • Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Medical Care. 1992;30:473–83.
  • Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20:649–55.
  • Cohen J. Statistical power analysis for the behavioural sciences. Hillsdale, NJ: Laurence Erlbaum Associates. Inc; 1988.
  • Felgoise SH, Chakraborty BH, Bond E, Rodriguez J, Bremer BA, Walsh SM, et al. Psychological morbidity in ALS: the importance of psychological assessment beyond depression alone. Amyotroph Lateral Scler. 2010;11:351–8.
  • de Wit J, Bakker LA, van Groenestijn AC, van den Berg LH, Schröder CD, Visser-Meily JM, et al. Caregiver burden in amyotrophic lateral sclerosis: a systematic review. Palliat Med. 2018;32:231–45.
  • Pagnini F. The potential role of illness expectations in the progression of medical diseases. BMC Psychol. 2019;7:1–5.
  • Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J Med. 2020;382:554–61.
  • Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.